300759.SZ
康龙化成
SZSE · Healthcare · M 科研服务 · CN
CNY 44.86
−6.50%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 14.6B | 14.1B | 12.3B | 11.5B | 10.3B |
| Cost of Revenue | 9.5B | 9.2B | 8.1B | 7.4B | 6.5B |
| Gross Profit | 5.0B | 4.9B | 4.2B | 4.1B | 3.8B |
| Operating Expenses | |||||
| R&D Expense | 593.6M | 576.0M | 469.3M | 448.3M | 282.3M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 1.8B | 1.7B | 1.6B | 1.6B | 1.5B |
| Selling & Marketing Expense | 315.7M | 306.5M | 258.4M | 252.8M | 230.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 3.0B | 2.9B | 2.6B | 2.4B | 2.3B |
| Cost and Expenses | 12.6B | 12.1B | 10.6B | 9.8B | 8.8B |
| Operating Income (EBIT) | 2.0B | 1.9B | 2.1B | 1.8B | 1.7B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 2.0B | 1.9B | 2.1B | 1.8B | 1.7B |
| Income Tax Expense | 375.9M | 357.5M | 377.1M | 256.1M | 314.3M |
| Bottom Line | |||||
| Net Income | 1.7B | 1.7B | 1.8B | 1.6B | 1.4B |
| Earnings from Cont. Ops | 1.6B | 1.6B | 1.7B | 1.6B | 1.4B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.7B | 1.7B | 1.8B | 1.6B | 1.4B |
| Per Share | |||||
| Basic EPS | CN¥0.96 | CN¥0.94 | CN¥1.01 | CN¥0.90 | CN¥0.78 |
| Diluted EPS | CN¥0.96 | CN¥0.94 | CN¥1.01 | CN¥0.90 | CN¥0.77 |
| Revenue Per Share | CN¥8.08 | CN¥8.00 | CN¥6.94 | CN¥6.51 | CN¥5.79 |
| Shares | |||||
| Basic Shares Outstanding | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B |
| Diluted Shares Outstanding | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B |
| Profitability Metrics | |||||
| EBITDA | — | 3.0B | 3.1B | 2.7B | 2.3B |
| D&A | — | 1.1B | 974.9M | 822.6M | 630.6M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026